Rybelsus (Semaglutide) – The First Oral GLP-1 Treatment for Type 2 Diabetes

Rybelsus is a groundbreaking prescription medication used to help adults manage type 2 diabetes. As the first oral GLP-1 receptor agonist, Rybelsus helps lower blood sugar by stimulating insulin release, decreasing glucagon, and slowing gastric emptying. It supports weight management and improved A1C levels when combined with a healthy diet and regular exercise. With the convenience of a once-daily pill, Rybelsus offers an effective and easy-to-use alternative to injections, helping reduce the risk of long-term diabetes complications.